Medtronic plc
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Geoffrey Straub Martha
- Full Time Employees
- 95,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 20 On Hatch Galway Ireland 2
- IPO Date
- May 2, 1973
- CIK
- 0001613103
- Website
- medtronic.com
- Similar Companies
- Business
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Company News
Why Is Medtronic (MDT) Up 6% Since Last Earnings Report?
6 Upcoming Dividend Increases
I'm Buying Dividend Aristocrats At Bargain Basement Prices
Medtronic: Solid Recent Performance But Better Options Available
Medtronic Is Separating Its Diabetes Business - Good News For Investors
3 Monster Dividend Stocks to Hold for the Next 10 Years
Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead?
Medtronic announces MiniMed as name for planned New Diabetes Company
5 Things You Need to Know If You Buy Medtronic Today
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Medtronic Announces Intent To Spin Diabetes Business
Medtronic Just Announced a Move That Its Shareholders Should Love
I'm Buying 2 Must-Own Dividend Bargains
Does This Move Make Medtronic Stock a Buy?
Medtronic plc (MDT) Bernstein's 41st Strategic Decisions Conference - (Transcript)
ISRG vs. MDT: Which Robotic Surgery Stock Is a Smarter Buy Now?
We compared 5 Dividend Aristocrats, this one came out on top
No Rolex For Me - I'm Buying Dividends That Pay For Life
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference